Acute Lymphoblastic Leukemia Current Events | Acute Lymphoblastic Leukemia News | 10
|
| Page
10 of
26 |
504 Results |
|
|
|
Sort By:
Page Views | Date |
Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center. view more (2007-06-04)
Better treatment selection and improved therapies -- key to improving prognosis in acute HF
Today, acute heart failure represents the most common reason for hospitalisation in the over-65 population. view more (2009-06-01)
Inhibition of GRK2 is protective against acute cardiac stress injuries
Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion. view more (2009-11-18)
Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. view more (2008-11-04)
Implementation of acute care surgery service provides more timely patient care
A new study published in the October issue of the Journal of the American College of Surgeons shows that the establishment of an acute care surgery service can help surgeons at academic medical centers provide more timely care to the growing number of patients who are transferred from the emergency room or smaller hospitals and who require an... view more... (2009-10-12)
The good and bad side of anti-cancer compounds
Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear. view more (2008-04-11)
NEW DRUG TREATMENT COULD PROVIDE LONG-TERM BENEFIT FOR HEART-ATTACK PATIENTS (p 1385)
Patients with acute myocardial infarction (heart attack), complicated by left-ventricular systolic dysfunction, could benefit from the ß-blocker carvedilol, conclude authors of a study in this week's issue of THE LANCET. In a randomised, placebo-controlled trial, this drug reduced the frequency of death from all causes, death from... view more... (2001-05-03)
Immune therapy could treat leukemias, autoimmune diseases, transplant rejection
In studies with mice, treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias, autoimmune diseases and transplant rejection. view more (2005-10-12)
What is the clinical character of Fitz-Hugh-Curtis syndrome?
Fitz-Hugh-Curtis syndrome is characterized by inflammation in perihepatic capsules with concomitant pelvic inflammation. The pain in the right upper abdomen appeared as the main symptom. view more (2008-12-23)
ESC Congress 2003: Absent effect of aspirin in patients with acute myocardial infarction
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Clot-busters - do they work for all? Aspirin is given to patients... view more... (2003-09-01)
Lipid lowering therapy reduces short-term deaths after heart attack, new findings show
New research findings published in this week’s issue of The Lancet have added more fuel to the debate over the merits of lipid lowering therapy to improve the survival chances of heart attack patients. The findings, from an international study involving investigators from USA, UK, Hungary, France and Canada, showed that patients treated for... view more... (2001-04-06)
Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree
Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas. view more (2009-10-28)
A search for protection against chemotherapy cardiotoxicity
Researchers at the University of Grenoble, in France, have discovered that erythropoietin administration prevents acute cardiotoxic effects induced by doxorubicin and trastuzumab exposures. view more (2007-12-21)
Constipation most common cause of children's abdominal pain
A new study led by a University of Iowa researcher showed that acute and chronic constipation together accounted for nearly half of all cases of acute abdominal pain in children treated at one hospital. view more (2007-12-18)
New mathematical model more accurately diagnoses acute heart failure in emergency rooms
Researchers at St. Michael's Hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (AHF) in emergency room patients. view more (2009-10-16)
Early warning for acute kidney injury
Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown. view more (2007-08-02)
Should intra-abdominal pressure measurement be a routine for all pancreatitis patients?
Acute pancreatitis remains a disease with an unpredictable clinical course, and significant associated morbidity and mortality. Recently, the elevated intraabdominal pressure (IAP) after onset of acute pancreatitis has gained growing attention, because it is increasingly recognized as an important risk factor for mortality in the early phase of... view more... (2009-02-19)
Some common treatments for sinus infections may not be effective
A comparison of common treatments for acute sinusitis that included an antibiotic and a topical steroid found neither more effective than placebo, according to a study in the December 5 issue of JAMA. view more (2007-12-05)
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today. view more (2009-03-27)
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today. view more (2009-03-26)
|
|
| Page
10 of
26 |
504 Results |
|
|
|
Sort By:
Page Views | Date |
|
